Related Experiment Videos
Peripheral and central conduction abnormalities in diabetes mellitus.
C Suzuki1, I Ozaki, M Tanosaki
1Third Department of Medicine, Hirosaki University School of Medicine, Hirosaki, Japan.
Neurology
|May 24, 2000
Summary
Diabetic neuropathy affects both central and peripheral somatosensory pathways, indicated by prolonged latencies in somatosensory evoked potentials (SEPs). This central conduction time abnormality occurs independently of peripheral nerve conduction slowing.
Area of Science:
- Neuroscience
- Diabetology
- Clinical Electrophysiology
Background:
- Diabetic polyneuropathy is a common complication of diabetes mellitus.
- Understanding the impact of diabetes on somatosensory pathways is crucial for diagnosis and management.
Purpose of the Study:
- To investigate peripheral and central somatosensory conduction abnormalities in patients with diabetes.
- To differentiate the roles of central versus peripheral nerve dysfunction in diabetic neuropathy.
Main Methods:
- Somatosensory evoked potentials (SEPs) and sensory nerve action potentials were recorded in 55 diabetic patients and 41 controls.
- Analysis included latencies of Erb's potential (N9), spinal (N13-P13), and cortical (N20-P20) SEP components.
- Central conduction time (CCT) was calculated using onset-to-onset and peak-to-peak measurements.
Main Results:
- Patients with diabetes exhibited prolonged onset and peak latencies for all SEP components.
- Mean onset CCT was significantly longer in diabetics, but peak CCT showed no significant difference.
- Peripheral sensory conduction velocity was reduced in diabetics, with no correlation to onset CCT prolongation.
Conclusions:
- Diabetes impairs conductive function in both central and peripheral somatosensory pathways.
- Central conduction time abnormalities in diabetes are not directly linked to peripheral conduction slowing.
- Findings do not support a central-peripheral distal axonopathy as the primary mechanism for diabetic polyneuropathy.